Xontogeny LLC is a US-based life sciences accelerator dedicated to collaborating with entrepreneurs, scientific founders, and first-time CEOs to drive the successful development of innovative technologies. The company provides comprehensive guidance and operational support in drug and technology development, aiming to enable new treatment options for patients with serious diseases. Xontogeny focuses on fostering early-stage biotech ventures, ensuring they have the expertise and resources needed to succeed.
Xontogeny has made significant strides in the biotech industry, exemplified by its involvement in launching Neurosterix with $63 million to advance allosteric modulator therapeutics for neurological disorders. The company's impact is amplified through its experienced team and extensive network of industry consultants, which together help translate scientific discoveries into viable medical treatments.
